Circulating cytokine dynamics as potential biomarker of response to anti-PD-1 immunotherapy in BRAFwt MM patients

Circulating cytokine dynamics as potential biomarker of response to anti-PD-1 immunotherapy in BRAFwt MM patients

Background: The biomarkers of immune checkpoint inhibitors (ICIs) efficacy and safety are still urgently needed. As cytokines are easily detected and monitored in circulation, they could be used as potential predictors of response and immune-related adverse events (irAEs) for ICIs therapy. Methods:...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Katarina Mirjačić Martinović, Ana Vuletić, Nevena Tišma Miletić, Irina Besu Žižak, Jelena Milovanović, Suzana Matković, Vladimir Jurišić
Формат:	Өгүүллэг
Хэл сонгох:	English
Хэвлэсэн:	Elsevier 2023-12-01
Цуврал:	Translational Oncology
Нөхцлүүд:	Metastatic melanoma patients BRAF wild type Pembrolizumab Cytokines Monitoring Outcome predictors
Онлайн хандалт:	http://www.sciencedirect.com/science/article/pii/S1936523323001857

Ижил төстэй зүйлс

Complete response in a patient with BRAF-mutant metastatic melanoma achieved with the multidisciplinary approach: a case report
-н: Hana Garaj, зэрэг
Хэвлэсэн: (2024-01-01)

Factors influencing the prognosis in Braf wild-type metastatic malignant melanoma and the role of novel inflammation indices
-н: Senar Ebinç, зэрэг
Хэвлэсэн: (2023-09-01)

A Case of Severe Diabetic Ketoacidosis Associated with Pembrolizumab Therapy in a Patient with Metastatic Melanoma
-н: Wu L, зэрэг
Хэвлэсэн: (2021-02-01)

Increased circulating monocyte MDSCs positively correlate with serum Interleukin-10 in metastatic melanoma patients
-н: Katarina Mirjačić Martinović, зэрэг
Хэвлэсэн: (2023-04-01)

Combination Atezolizumab, Cobimetinib, and Vemurafenib as a Treatment Option in BRAF V600 Mutation–Positive Melanoma: Patient Selection and Perspectives
-н: Dugan MM, зэрэг
Хэвлэсэн: (2024-07-01)

Clinical significance of <it>BRAF </it>mutations in metastatic melanoma
-н: Polsky David, зэрэг
Хэвлэсэн: (2004-12-01)

A Rare Complex BRAF Mutation Involving Codon V600 and K601 in Primary Cutaneous Melanoma: Case Report
-н: Francesca Consoli, зэрэг
Хэвлэсэн: (2020-07-01)

Case report: Exceptional disease progression in a 70-year-old patient: generalized melanosis and melanuria in the course of metastatic melanoma - a case study
-н: Jacek Calik, зэрэг
Хэвлэсэн: (2024-01-01)

Real‐world survival of patients with advanced BRAF V600 mutated melanoma treated with front‐line BRAF/MEK inhibitors, anti‐PD‐1 antibodies, or nivolumab/ipilimumab
-н: Justin C. Moser, зэрэг
Хэвлэсэн: (2019-12-01)

Case report: Concurrent intrathecal and intravenous pembrolizumab for metastatic melanoma with leptomeningeal disease
-н: Xiang Dan, зэрэг
Хэвлэсэн: (2024-04-01)

PEMBROLIZUMAB IN THE TREATMENT OF METASTATIC MELANOMA
-н: I. V. SAMOILENKO, зэрэг
Хэвлэсэн: (2017-06-01)

Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive <i>BRAF</i> Mutant Advanced Melanoma
-н: Ernesto Rossi, зэрэг
Хэвлэсэн: (2023-01-01)

A phase I, single‐center, open‐label study to investigate the absorption, distribution, metabolism and excretion of encorafenib following a single oral dose of 100 mg [14C] encorafenib in healthy male subjects
-н: Lance Wollenberg, зэрэг
Хэвлэсэн: (2023-10-01)

Potential utilization of neopterin measurements in the assessment of pyrexia in metastatic melanoma treated with combined targeted therapy: a case report
-н: Bartoušková Marie, зэрэг
Хэвлэсэн: (2020-08-01)

Systemic therapy of skin metastatic melanoma with BRAF gene mutation
-н: Yu. S. Shakh-Paronyants, зэрэг
Хэвлэсэн: (2023-03-01)

A Dramatic Response to Second-Line Nivolumab and Ipilimumab in BRAF-V600-Mutated Metastatic Melanoma
-н: Dahlia Fedele, зэрэг
Хэвлэсэн: (2024-01-01)

Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma
-н: Saba S. Shaikh, зэрэг
Хэвлэсэн: (2022-11-01)

Detection of humoral and cellular immune response to anti-SARS-CoV-2 BNT162b2 vaccine in breastfeeding women and naïve and previously infected individuals
-н: Milena Cavic, зэрэг
Хэвлэсэн: (2023-04-01)

Melanoma: BRAFi Rechallenge
-н: Christoforos S. Kosmidis, зэрэг
Хэвлэсэн: (2023-05-01)

Limbic encephalitis in metastatic malignant melanoma patient induced by PD-1 checkpoint inhibitor pembrolizumab
-н: Rozala Arko, зэрэг
Хэвлэсэн: (2022-07-01)

MEK inhibitors for the treatment of NRAS mutant melanoma
-н: Sarkisian S, зэрэг
Хэвлэсэн: (2018-08-01)

The Human Melanoma Proteome Atlas—Complementing the melanoma transcriptome
-н: Lazaro Hiram Betancourt, зэрэг
Хэвлэсэн: (2021-07-01)

Current State of Target Treatment in BRAF Mutated Melanoma
-н: Enrica Teresa Tanda, зэрэг
Хэвлэсэн: (2020-07-01)

Fertility Outcomes and Sperm-DNA Parameters in Metastatic Melanoma Survivors Receiving Vemurafenib or Dabrafenib Therapy: Case Report
-н: Marco Ghezzi, зэрэг
Хэвлэсэн: (2020-03-01)

Novel 5,6-dichlorobenzimidazole derivatives as dual BRAFWT and BRAFV600E inhibitors: design, synthesis, anti-cancer activity and molecular dynamics simulations
-н: Ahmed Temirak, зэрэг
Хэвлэсэн: (2025-02-01)

Update on the treatment of BRAFmut metastatic melanoma and future perspectives
-н: Peter Mohr, зэрэг
Хэвлэсэн: (2025-03-01)

BRAF-MEK inhibitors as steroid-sparing bridge prior to checkpoint blockade therapy in symptomatic intracranial melanoma
-н: Karam Khaddour, зэрэг
Хэвлэсэн: (2021-06-01)

Triple combination of vemurafenib, cobimetinib, and atezolizumab in real clinical practice in the Russian Federation: results of the A1 cohort of the ISABELLA study
-н: Igor V. Samoylenko, зэрэг
Хэвлэсэн: (2024-10-01)

Improved overall survival in dual compared to single immune checkpoint inhibitors in BRAF V600-negative advanced melanoma
-н: Adi Kartolo, зэрэг
Хэвлэсэн: (2022-03-01)

BRAF L485–P490 deletion mutant metastatic melanoma sensitive to BRAF and MEK inhibition: A case report and literature review
-н: Simeng Zhang, зэрэг
Хэвлэсэн: (2023-01-01)

Rapidly progressing metastatic malignant melanoma mimicking primary pleural tumor: A case report
-н: Clara So, зэрэг
Хэвлэсэн: (2022-05-01)

Braf protein mutation and its significancy within patients with melanoma
-н: Julia Kuchnicka, зэрэг
Хэвлэсэн: (2022-08-01)

Treatment of Advanced Melanoma: Past, Present and Future
-н: Taku Fujimura, зэрэг
Хэвлэсэн: (2020-09-01)

Comparison of Two Rapid Assays for the Detection of <i>BRAF</i> V600 Mutations in Metastatic Melanoma including Positive Sentinel Lymph Nodes
-н: Elodie Long-Mira, зэрэг
Хэвлэсэн: (2022-03-01)

Safety and rapid response of dabrafenib and trametinib therapy during hyperbilirubinemia in metastatic melanoma
-н: Walid Shalata, зэрэг
Хэвлэсэн: (2023-02-01)

Case Report: Dynamic overlap of melanoma, sarcoidosis, and targeted therapy for BRAF-mutant melanoma
-н: Nakul Dar, зэрэг
Хэвлэсэн: (2023-08-01)

Tyrosine kinase inhibitors via nasogastric tube may resolve severe ileus secondary to melanoma: A case report
-н: Lena Groennendijk, зэрэг
Хэвлэсэн: (2022-06-01)

Treatment beyond progression and locoregional approaches in selected patients with BRAF-mutated metastatic melanoma
-н: Francesco Serra, зэрэг
Хэвлэсэн: (2021-08-01)

Association between braf gene mutation status and clinical-morphological features of cutaneous melanoma
-н: O. I. Kit, зэрэг
Хэвлэсэн: (2016-06-01)

Early Reassessment of Total Metabolic Tumor Volume on FDG-PET/CT in Advanced Melanoma Patients Treated with Pembrolizumab Predicts Long-Term Outcome
-н: Sim Vermeulen, зэрэг
Хэвлэсэн: (2021-04-01)